Education
About Us
Working with TipRanks
Follow Us
Biotricity (BTCY)
:BTCY
Earnings Data
Report Date
Nov 12, 2025Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.07Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Q4 2025
Earnings Call Date:Jul 17, 2025|
% Change Since: 35.90%|
Earnings Call Sentiment|Positive
Biotricity showed significant advancements and strategic partnerships leading to revenue growth and reduced operating expenses, positioning the company close to profitability. Despite ongoing net losses and long sales cycles, the positive developments, such as international approvals and gross margin improvements, indicate a strong trajectory towards sustainable growth.Company Guidance -
Q2 2026
Expansion of Cardiac AI Cloud Platform
Biotricity expanded its Cardiac AI cloud platform through strategic partnerships with Amazon AWS and Google TensorFlow, leveraging over 1 trillion heartbeats of anonymized data. This platform aims to enhance diagnostic accuracy and improve patient outcomes.
Strategic Alliances with Group Purchasing Organizations (GPOs)
Biotricity formed partnerships with three major GPOs, allowing access to approximately 90% of hospitals in the U.S., significantly expanding market reach.
Revenue Growth
For the fourth quarter ended March 31, 2025, revenue increased by 16.5% year-over-year to $3.7 million, and for the fiscal year, revenue rose by 14.3% to $13.8 million.
Positive Adjusted EBITDA
Achieved positive adjusted EBITDA of $438,000 for the last quarter of fiscal 2025, indicating progress towards profitability.
Gross Profit and Margin Improvement
Gross profit for the quarter increased by 31% to $3 million, with a gross margin improvement of over 890 basis points to 80.4%.
Operating Expenses Reduction
Operating expenses for the fiscal year decreased by 24.5% to $13 million, with SG&A expenses down by 30.2% and R&D expenses reduced by 19.2%.
International Approvals and Expansion
Received Health Canada approval and regulatory approval in Saudi Arabia, opening new revenue streams in international markets.
BTCY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BTCY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2025 | $0.54 | $0.54 | 0.00% |
Jul 17, 2025 | $0.38 | $0.39 | +2.63% |
Feb 20, 2025 | $0.66 | $0.64 | -3.03% |
Nov 15, 2024 | $0.40 | $0.45 | +12.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Biotricity (BTCY) report earnings?
Biotricity (BTCY) is schdueled to report earning on Nov 12, 2025, Before Open (Confirmed).
What is Biotricity (BTCY) earnings time?
Biotricity (BTCY) earnings time is at Nov 12, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BTCY EPS forecast?
BTCY EPS forecast for the fiscal quarter 2026 (Q2) is -0.08.